A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants

Trial Identifier: D5672C00001
Sponsor: MedImmune, LLC
NCTID:: NCT03625778
Start Date: August 2018
Primary Completion Date: August 2019
Condition: Obesity

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Spanish Translation

Trial Locations

Country Location
United States of America, FL Daytona Beach, FL, United States of America, 32117
United States of America, TX Dallas, TX, United States of America, 75247